This correlation proposed that the elevated CTRP3 levels in T2D could be a compensatory mechanism developed in long standing DM to decrease the state of hyperglycemia through altering the increased insulin resistance (IR) and decreased insulin sensitivity (measured by QUICKI) present in these patients. This evidence concerns the gene C1QTNF3 and type 2 diabetes mellitus.